Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Selectis Health ( (GBCS) ) has issued an announcement.
On June 20, 2025, Selectis Health was informed by the OTC Markets Group, Inc. that its common stock received approval for upgraded quotation on the OTCQB. Trading under the ticker symbol ‘GBCS’ is set to commence on June 23, 2025, marking a significant step in enhancing the company’s market visibility and accessibility.
Spark’s Take on GBCS Stock
According to Spark, TipRanks’ AI Analyst, GBCS is a Underperform.
The overall score reflects significant financial challenges, including net losses and high leverage. Technical analysis suggests potential volatility with overbought indicators. Valuation concerns arise from the negative P/E ratio and lack of dividend yield. These factors combined indicate a high-risk investment environment for Selectis Health.
To see Spark’s full report on GBCS stock, click here.
More about Selectis Health
Average Trading Volume: 1,332
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.91M
Find detailed analytics on GBCS stock on TipRanks’ Stock Analysis page.